Rodgers Brothers’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $667K | Hold |
1,897
| – | – | 0.08% | 161 |
|
|
2025
Q4 | $621K | Hold |
1,897
| – | – | 0.07% | 168 |
|
|
2025
Q3 | $535K | Sell |
1,897
-30
| -2% | -$8.7K | 0.07% | 182 |
|
|
2025
Q2 | $538K | Sell |
1,927
-340
| -15% | -$96.3K | 0.07% | 184 |
|
|
2025
Q1 | $706K | Sell |
2,267
-110
| -5% | -$32.5K | 0.09% | 154 |
|
|
2024
Q4 | $620K | Hold |
2,377
| – | – | 0.08% | 166 |
|
|
2024
Q3 | $766K | Hold |
2,377
| – | – | 0.1% | 152 |
|
|
2024
Q2 | $743K | Buy |
2,377
+88
| +4% | +$25.9K | 0.1% | 150 |
|
|
2024
Q1 | $651K | Hold |
2,289
| – | – | 0.09% | 156 |
|
|
2023
Q4 | $659K | Hold |
2,289
| – | – | 0.1% | 148 |
|
|
2023
Q3 | $615K | Sell |
2,289
-5,800
| -72% | -$1.45M | 0.11% | 146 |
|
|
2023
Q2 | $1.8M | Buy |
8,089
+6
| +0.1% | +$1.39K | 0.32% | 83 |
|
|
2023
Q1 | $1.95M | Buy |
8,083
+6,160
| +320% | +$1.51M | 0.38% | 72 |
|
|
2022
Q4 | $505K | Hold |
1,923
| – | – | 0.1% | 149 |
|
|
2022
Q3 | $433K | Hold |
1,923
| – | – | 0.09% | 164 |
|
|
2022
Q2 | $468K | Sell |
1,923
-2,427
| -56% | -$595K | 0.09% | 161 |
|
|
2022
Q1 | $1.05M | Buy |
4,350
+100
| +2% | +$23K | 0.19% | 113 |
|
|
2021
Q4 | $956K | Sell |
4,250
-3,325
| -44% | -$702K | 0.17% | 128 |
|
|
2021
Q3 | $1.61M | Sell |
7,575
-72
| -0.9% | -$16.6K | 0.32% | 82 |
|
|
2021
Q2 | $1.86M | Buy |
7,647
+25
| +0.3% | +$6.15K | 0.36% | 76 |
|
|
2021
Q1 | $1.9M | Buy |
7,622
+5,730
| +303% | +$1.37M | 0.39% | 69 |
|
|
2020
Q4 | $435K | Hold |
1,892
| – | – | 0.1% | 147 |
|
|
2020
Q3 | $481K | Hold |
1,892
| – | – | 0.12% | 136 |
|
|
2020
Q2 | $446K | Sell |
1,892
-62
| -3% | -$14.1K | 0.12% | 140 |
|
|
2020
Q1 | $396K | Hold |
1,954
| – | – | 0.13% | 138 |
|
|
2019
Q4 | $471K | Hold |
1,954
| – | – | 0.12% | 141 |
|
|
2019
Q3 | $378K | Sell |
1,954
-6,125
| -76% | -$1.18M | 0.1% | 158 |
|
|
2019
Q2 | $1.49M | Buy |
8,079
+2,808
| +53% | +$503K | 0.41% | 67 |
|
|
2019
Q1 | $1M | Buy |
5,271
+2,176
| +70% | +$416K | 0.29% | 85 |
|
|
2018
Q4 | $603K | Sell |
3,095
-1,800
| -37% | -$351K | 0.19% | 100 |
|
|
2018
Q3 | $1.01M | Sell |
4,895
-630
| -11% | -$124K | 0.29% | 77 |
|
|
2018
Q2 | $1.02M | Buy |
5,525
+151
| +3% | +$26.7K | 0.31% | 72 |
|
|
2018
Q1 | $916K | Buy |
5,374
+916
| +21% | +$168K | 0.3% | 71 |
|
|
2017
Q4 | $775K | Buy |
4,458
+1
| +0% | +$177 | 0.25% | 77 |
|
|
2017
Q3 | $831K | Buy |
4,457
+201
| +5% | +$35.6K | 0.29% | 72 |
|
|
2017
Q2 | $733K | Buy |
4,256
+501
| +13% | +$81.5K | 0.27% | 78 |
|
|
2017
Q1 | $616K | Buy |
3,755
+1,400
| +59% | +$233K | 0.23% | 88 |
|
|
2016
Q4 | $344K | Hold |
2,355
| – | – | 0.13% | 124 |
|
|
2016
Q3 | $393K | Buy |
2,355
+70
| +3% | +$11.8K | 0.16% | 116 |
|
|
2016
Q2 | $348K | Buy |
2,285
+750
| +49% | +$117K | 0.14% | 126 |
|
|
2016
Q1 | $230K | Buy |
1,535
+150
| +11% | +$22.3K | 0.1% | 152 |
|
|
2015
Q4 | $225K | Buy |
+1,385
| New | +$218K | 0.11% | 149 |
|
|
2015
Q3 | – | Sell |
-1,385
| Closed | -$213K | – | 158 |
|
|
2015
Q2 | $213K | Sell |
1,385
-100
| -7% | -$16K | 0.1% | 152 |
|
|
2015
Q1 | $237K | Hold |
1,485
| – | – | 0.12% | 138 |
|
|
2014
Q4 | $237K | Hold |
1,485
| – | – | 0.12% | 133 |
|
|
2014
Q3 | $209K | Buy |
+1,485
| New | +$194K | 0.11% | 137 |
|
Other funds holding AMGN
VCM
VPM
Rodgers Brothers's AMGN Position: Q1 2026 in Review
Rodgers Brothers held its Amgen (AMGN) position steady in Q1 2026 at 1,897 shares worth $667K. The position accounts for 0.08% of the portfolio, ranked #161.
Rodgers Brothers first reported a position in AMGN in Q3 2014 and has held it in 46 quarters since. The position peaked at $1.95M in Q1 2023. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Rodgers Brothers held 1,897 shares of Amgen worth $667K as of Q1 2026.
- Rodgers Brothers left its Amgen share count unchanged in Q1 2026.
- Amgen made up 0.08% of Rodgers Brothers's portfolio in Q1 2026, its #161 holding.
- Rodgers Brothers first reported a position in Amgen in Q3 2014 and has held it in 46 quarters since.
- Rodgers Brothers's Amgen position peaked at $1.95M in Q1 2023.
- 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Rodgers Brothers's 13F filing for Q1 2026, filed 14 May 2026.